AOC GMP Manufacture for a FIH Study Case Study

Access our latest antibody-oligonucleotide conjugate (AOC) case study on a fAb conjugated with a PMO for a muscular dystrophy treatment. The case study focuses on our streamlined approach for GMP manufacturing for a first-in-human (FIH) clinical study.

Download the case study below

You May Also be Interested in